semaglutide hepatic impairment child-pugh in MASLD Patients: Improved Survival and Liver Outcomes Semaglutide targets MASH molecular pathways

2009 Mar;25(3):340-9

E.AlbertN

Correlation between gastrointestinal fungi and varying degrees of chronic hepatitis B virus infection

These services offer multidisciplinary support and, where clinically indicated, access to pharmacological treatments, in line with NICE obesity guidance (NICE CG189 and quality standard QS127, alongside relevant technology appraisals)

Hubbard GK, Mutton LN, Khalili M, McMullin RP, Hicks JL, Bianchi-Frias D, Horn LA, Kulac I, Moubarek MS, Nelson PS, et al

Retatrutide, a new medication created by the pharmaceutical company Eli Lilly, has a major potential for treating obesity and diabetes